Would you consider definitive chemoradiation followed by surgery for esophageal adenocarcinoma with a single distant metastatic site?

The management of oligometastatic esophagogastric cancer is a controversial and evolving topic. For many years, our disease management team (DMT) shied away from such an approach, in large part because of the results of the phase III REGATTA study (Fujitani et al., PMID 26822397). This Japanese stud...